YENOM NOTICIAS
Noticias financieras organizadas para conectar titulares, símbolos, fuente, fecha y sentimiento con tu análisis y operativa.
Si escribes ticker, YENOM prioriza ese instrumento. Si lo dejas vacío puedes explorar el feed general o por tema.
More than 175 biotechs use pre-configured applications to streamline operations PLEASANTON, Calif., Oct. 7, 2026 /PRNewswire/ -- Veeva Systems (NYSE: VEEV) today announced that more than 175 emerging biotechs are establishing a technology…
PTK7 Expression Remained Stable Following Standard-of-Care Therapies, Supporting Its Relevance as a Target in Second- or Later-Line EGFR NSCLC Findings Reinforce the Scientific Rationale for HWK-007, Whitehawk's Next-Generation PTK7-Direct…
Former Incyte Executive Brings Extensive Oncology, Corporate Strategy, Business Development and Medical Affairs Experience MORRISTOWN, N.J., Sept. 10, 2026 /PRNewswire/ -- Whitehawk Therapeutics, Inc. (Nasdaq: WHWK), a clinical-stage oncol…
Whitehawk Therapeutics, Inc. (NASDAQ:WHWK), featuring a year-to-date gain of 71.49% and upside potential of 68.70%, secures a spot on our list of hot biotech stocks under $5 to buy.Is Whitehawk Therapeutics (WHWK) One Of The Hot Biotech St…
According to the SEC filing dated May 15, Acuta Capital Partners, LLC disclosed a first-quarter sale of 460,887 shares of Ocular Therapeutix(NASDAQ:OCUL). Reduced Ocular Therapeutix holdings by 460,887 shares Post-trade: 592,108 shares hel…
What happened According to an SEC filing dated May 15, 2026, Acuta Capital Partners, LLC initiated a new position in Erasca(NASDAQ:ERAS) during the first quarter. The fund acquired 354,575 shares, with an estimated transaction value of $4.…
MORRISTOWN, N.J., May 15, 2026 /PRNewswire/ -- Whitehawk Therapeutics, Inc. (Nasdaq: WHWK), a clinical-stage oncology therapeutics company applying advanced technologies to established tumor biology to efficiently deliver improved antibody…
Gainers Quantum Cyber (NASDAQ:QUCY) shares rose 163.0% to $0.85 during Wednesday's regular session. The market value of their outstanding shares is at $4.0 million. Whitehawk Therapeutics (NASDAQ:WHWK) stock moved upwards by 29.59% to $5.0…
Gainers Quantum Cyber (NASDAQ:QUCY) shares increased by 55.0% to $0.5 during Wednesday's pre-market session. The market value of their outstanding shares is at $4.0 million. SELLAS Life Sciences Gr (NASDAQ:SLS) shares increased by 21.26% t…
Tempus AI, Inc. TEM is expected to report fourth-quarter 2025 results on Feb. 24. In the last reported quarter, the company’s adjusted loss of 11 cents per share was narrower than the Zacks Consensus Estimate of a loss of 16 cents. Tempus…
Tempus AI TEM is slated to release fourth-quarter 2025 results on Feb. 24, after market close. During the quarter, the company advanced several strategic collaborations and product innovations that are expected to further strengthen its pe…
Tempus AI, Inc. TEM has achieved several significant milestones over the past year. The company recorded Total Contract Value (“TCV”) of more than $1.1 billion as of Dec. 31, 2025. It signed data agreements with more than 70 customers acro…
MORRISTOWN, N.J., Nov. 11, 2025 /PRNewswire/ -- Whitehawk Therapeutics, Inc. (Nasdaq: WHWK), an oncology therapeutics company applying advanced technologies to established tumor biology to efficiently deliver improved antibody drug conjuga…
* Whitehawk Therapeutics press release [https://seekingalpha.com/pr/20296637-whitehawk-therapeutics-reports-third-quarter-2025-financial-results-and-recent-highlights] (WHWK [https://seekingalpha.com/symbol/WHWK]): Q3 GAAP EPS of -$0.26 mi…
Tempus AI, Inc. recently announced a multi-year collaboration with Whitehawk Therapeutics, Inc. to utilize its real-world dataset in advancing biomarker-focused oncology research and optimizing patient selection for clinical trials targeti…
Tempus AI Inc. TEM maintains a solid pipeline of collaborations that align with its financial strategy and are expected to enhance its inorganic growth. Recently, Tempus has entered a multi-year partnership with Whitehawk Therapeutics, Inc…
[Using AI technology helps with genetic code prediction research.] Suriphon Singha/iStock via Getty Images * Tempus AI (NASDAQ:TEM [https://seekingalpha.com/symbol/TEM]) has partnered with Whitehawk Therapeutics (NASDAQ:WHWK [https://seeki…
CHICAGO, October 16, 2025--(BUSINESS WIRE)--Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine, today announced a multi-year collaboration with Whitehawk Therapeutics, Inc. (NASDAQ:…
Company Logo The United States Personalized Medicine Market is projected to soar to US$ 307.04 billion by 2033 from US$ 169.56 billion in 2024, experiencing a CAGR of 6.82% from 2025 to 2033. Key growth drivers include advances in next-gen…
MORRISTOWN, N.J., June 19, 2025 /PRNewswire/ -- Whitehawk Therapeutics, Inc. (Nasdaq: WHWK), an oncology therapeutics company applying advanced technologies to established tumor biology to efficiently deliver improved ADC cancer treatments…
Whitehawk Therapeutics, Inc. (NASDAQ:WHWK), a pharmaceutical company with a market capitalization of $94 million, announced the outcomes of its annual stockholders’ meeting held on June 11, 2025. According to InvestingPro analysis, the com…